Ligand Pharmaceuticals, Inc. (LGND)
302.96
+0.22
(+0.07%)
USD |
NASDAQ |
Oct 02, 16:00
302.87
-0.09
(-0.03%)
After-Hours: 20:00
Ligand Pharmaceuticals Price : 302.96 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 307.55 | 307.63 | 301.32 | 302.96 | 179228.0 |
| Oct 01, 2026 | 309.82 | 312.05 | 301.48 | 302.74 | 374019.0 |
| Sep 30, 2026 | 310.52 | 317.23 | 306.95 | 312.37 | 505862.0 |
| Sep 29, 2026 | 313.63 | 317.10 | 304.36 | 310.36 | 430962.0 |
| Sep 28, 2026 | 299.78 | 314.94 | 299.70 | 314.10 | 241742.0 |
| Sep 25, 2026 | 303.17 | 305.34 | 293.90 | 301.52 | 305797.0 |
| Sep 24, 2026 | 296.95 | 303.41 | 296.37 | 299.04 | 210275.0 |
| Sep 23, 2026 | 300.44 | 302.44 | 296.08 | 298.41 | 242198.0 |
| Sep 22, 2026 | 291.00 | 300.48 | 289.00 | 298.50 | 308766.0 |
| Sep 21, 2026 | 283.67 | 290.51 | 282.45 | 290.07 | 237475.0 |
| Sep 18, 2026 | 285.63 | 285.64 | 280.49 | 283.49 | 372802.0 |
| Sep 17, 2026 | 279.51 | 285.51 | 273.10 | 284.70 | 248808.0 |
| Sep 16, 2026 | 277.97 | 278.74 | 271.22 | 275.20 | 299045.0 |
| Sep 15, 2026 | 280.53 | 280.53 | 270.77 | 276.98 | 180228.0 |
| Sep 14, 2026 | 284.93 | 287.14 | 280.12 | 280.65 | 158775.0 |
| Sep 11, 2026 | 291.48 | 294.00 | 283.77 | 284.47 | 261167.0 |
| Sep 10, 2026 | 285.00 | 291.26 | 283.04 | 289.25 | 146553.0 |
| Sep 09, 2026 | 288.03 | 291.82 | 285.48 | 288.05 | 309964.0 |
| Sep 08, 2026 | 285.05 | 289.28 | 278.40 | 288.83 | 216423.0 |
| Sep 04, 2026 | 287.41 | 290.00 | 285.47 | 285.60 | 132389.0 |
| Sep 03, 2026 | 286.92 | 290.08 | 281.88 | 289.74 | 190729.0 |
| Sep 02, 2026 | 285.73 | 290.33 | 281.69 | 286.92 | 189615.0 |
| Sep 01, 2026 | 286.28 | 290.41 | 281.99 | 284.27 | 185017.0 |
| Aug 31, 2026 | 276.77 | 285.90 | 275.60 | 284.10 | 203702.0 |
| Aug 28, 2026 | 283.70 | 284.00 | 277.36 | 280.49 | 127696.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 256.03 |
| Eli Lilly & Co. | 1142.85 |
| Merck & Co., Inc. | 144.30 |
| Zevra Therapeutics, Inc. | 9.99 |
| Liquidia Corp. | 28.64 |
Price Related Metrics
| PE Ratio | 32.39 |
| PS Ratio | 21.76 |
| Price to Book Value | 6.238 |
| Price to Free Cash Flow | 52.77 |
| Earnings Yield | 3.09% |
| Market Cap | 6.035B |
| Operating PE Ratio | 63.17 |
| Normalized PE Ratio | 43.05 |